Reginster, J., Hattersley, G., Williams, G. C., Hu, M., Fitzpatrick, L. A., & Lewiecki, E. M. (2018). Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide. Calcif Tissue Int.
Chicago-tyylinen lähdeviittausReginster, Jean-Yves, Gary Hattersley, Gregory C. Williams, Ming-yi Hu, Lorraine A. Fitzpatrick, ja E. Michael Lewiecki. "Abaloparatide Is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared With Teriparatide." Calcif Tissue Int 2018.
MLA-viiteReginster, Jean-Yves, et al. "Abaloparatide Is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared With Teriparatide." Calcif Tissue Int 2018.